PDA

View Full Version : Latest Rheumatology News

  1. Supplements No Better Than Placebo In Slowing Cartilage Loss In Knees Of Osteoarthritis Patients
  2. Study Shows EUFLEXXA(R) Patients Report Significant Improvements In Osteoarthritis Of The Knee Pain Over A Six Month Period
  3. Access To Psychological Support And Self-Management Courses Could Ease The Emotional Burden Of Arthritis/Rheumatism, Survey Says
  4. Chronic Disease Keeping Older Australians Out Of The Workforce
  5. ACTEMRA(R) (tocilizumab) Studies To Be Featured At American College Of Rheumatology Annual Scientific Meeting
  6. Pfizer Reaches Agreements In Principle To Resolve Litigation Involving Its NSAID Pain Medications - $894 Million Settlements
  7. Rheumatoid Arthritis Rising Among Women
  8. First International Guidelines For Treatment Of Psoriatic Arthritis Developed
  9. Psoriatic Arthritis: First International Guidelines For Treatment
  10. Study Shows ENBREL(R) (etanercept) More Effective Than A DMARD In The Treatment Of Symptoms Of Ankylosing Spondylitis Patients
  11. CIMZIA(R) (Certolizumab Pegol) Provides Rapid And Sustained Relief From Signs And Symptoms Of Rheumatoid Arthritis For Two Years
  12. ACTEMRA (R) (tocilizumab) Significantly Reduced Signs And Symptoms Of Rheumatoid Arthritis In Patients Who Failed Prior Treatments
  13. Tociluzumab Quick And Effective For Rheumatoid Arthritis Patients
  14. More Patients With Early Erosive Rheumatoid Arthritis Treated With ORENCIA(R) And Methotrexate Achieved DAS28 (CRP)-Defined Remission Versus MTX Alone
  15. University Of Kentucky Launches Clinical Outcomes-Based Educational Initiative To Reinforce Rheumatoid Arthritis (RA) Standards Of Care
  16. Cimzia(R) Study Shows Rapid Reduction Of Symptoms And Inhibition Of Joint Damage Progression In RA
  17. Predicting Depression In People With Rheumatoid Arthritis
  18. Fibromyalgia Can No Longer Be Called The 'Invisible' Syndrome
  19. MRI Can Eliminate Unnecessary Surgery For Children With Suspected Musculosketal Infections
  20. Alternative Dosing Should Be Considered Due To Wide Variability In Rheumatoid Arthritis Drug
  21. Destruction Of Joints By Arthritis: Genetic Disorder Sheds Light On Enzyme's Role In Bone Metabolism
  22. New Therapeutic Target Identified For Rheumatoid Arthritis
  23. Rheumatoid Arthritis Breakthrough
  24. New Data Points To Long Lasting Beneficial Effects Of CEL-SCI's Rheumatoid Arthritis Vaccine
  25. New One-Stop Diabetic Rheumatology Clinic Is First In UK
  26. Rheumatoid Arthritis - Cimzia(R) Studies Show Significant Clinical Benefits For Mono- And Combination Therapy
  27. Key US Patent Granted On Antibodies Against GM-CSF To Treat Inflammatory Disorders (Rheumatoid Arthritis)
  28. Better Management More Important Than New Drugs For Arthritis
  29. Results From The First And Largest Collaborative Study Confirm Role Of EnbrelŽ In Psoriatic Arthritis
  30. Clinicians Debate Use Of Arthroscopy In Patients With Osteoarthritis
  31. Forest Laboratories, Inc. And Cypress Bioscience, Inc. Announce Positive Results Of Phase III Study Of Milnacipran For The Management Of Fibromyalgia
  32. Third Osteoarthritis Study This Year Reveals PycnogenolŽ Lowers Inflammatory Marker CRP
  33. CrystalGenomics Announces Positive Phase IIa Results For Osteoarthritis Study Of CG100649
  34. MabThera Inhibits The Destruction Of Joints In Patients With Early Rheumatoid Arthritis
  35. Phase III Study Showed RituxanŽ Decreased The Progression Of Joint Damage In Patients With Early Rheumatoid Arthritis (RA)
  36. Phase III Study Showed RituxanŽ Decreased The Progression Of Joint Damage In Patients With Early Rheumatoid Arthritis
  37. ESBATech's Antibody Fragment Enters Phase I/IIa Clinical Development In Osteoarthritis With The Potential For Disease-Modifying Activity
  38. Cause Of Cartilage Degeneration In Osteoarthritis Discovered By Scripps Research Scientists
  39. Gender Difference In Severity Of Rheumatoid Arthritis
  40. Novel Drugs Selectively Target Pathway Important In Rheumatoid Arthritis
  41. Greater Quadriceps Strength May Benefit Those With Knee Osteoarthritis
  42. Anakinra For Rheumatoid Arthritis: A Modest Benefit With Some Risk, Study Suggests
  43. Discovery Of A Key Protein Regulator Of Inflammation And Cell Death
  44. Gene Therapy Demonstrates Benefit In Patients With Rheumatoid Arthritis
  45. Patients With Rheumatoid Arthritis Benefit From Gene Therapy
  46. Exercise Does Not Appear To Raise Damage To Joints
  47. Current And Emerging Therapies Have No Advantage Over Enbrel In Reducing The Signs And Symptoms Of Rheumatoid Arthritis
  48. Callisto Pharmaceuticals Redirects Atiprimod Clinical Development To Treat Rheumatoid Arthritis
  49. Progression Slowed And Symptoms Of Knee Osteoarthritis Relieved By Chondroitin
  50. Rheumatoid Arthritis: Study Provides First Evidence Of Clinical Response To Gene Therapy
  51. UCB's Meeting With U.S. FDA Defines Path Forward For Cimzia(R) In Rheumatoid Arthritis.
  52. Nutra Pharma Subsidiary, ReceptoPharm, Files Patent Application For Novel Treatment Of Arthritis Using RPI-78
  53. Psoriatic Arthritis Treatment of Ustekinumab Effective, Study Suggests
  54. FDA Approves First Gout Drug For 40 Years
  55. Type Of Rheumatoid Arthritis Medication May Be Associated With Increased Risk For Shingles
  56. New Treatment Against Osteoarthritis: Orthokine Therapy Highly Effective Against Knee Arthritis After Two Years
  57. New NICE Guidelines To Help Thousands Of People With Rheumatoid Arthritis
  58. New NICE Guidelines Encourage Wider Use Of Anti-CCP Testing In Rheumatoid Arthritis
  59. Osteoarthritis Worsens With Excess Weight
  60. Osteoarthritis Worsens With Excess Weight
  61. Most Complementary Medicines Have No Effect For People With Rheumatoid Arthritis; Picture More Hopeful For Osteoarthritis Patients
  62. Ustekinumab In The Treatment Of Psoriatic Arthritis: Investigational Study Published
  63. FDA Approves First Gout Drug For 40 Years
  64. How Inflammatory Disease Causes Fatigue
  65. In Arthritis Patients, Inhibiting Proteins May Prevent Cartilage Breakdown
  66. New Treatment Against Osteoarthritis: Orthokine Therapy Highly Effective Against Knee Arthritis After Two Years
  67. New NICE Guidelines To Help Thousands Of People With Rheumatoid Arthritis
  68. Health Canada Approves SIMPONI(TM) (golimumab) For Treatment Of Rheumatoid Arthritis, Psoriatic Arthritis And Ankylosing Spondylitis
  69. Ultrasound Changes Care Of Some Patients With Rheumatic Conditions
  70. Chlamydia May Play Role In A Type Of Arthritis
  71. A Phase IIb Study Testing The Combination Of Methotrexate And CF101 In Rheumatoid Arthritis Patients Failed To Achieve Primary Efficacy Endpoint
  72. There Are More Than 100 Reasons To See A Rheumatologist
  73. Supplements No Better Than Placebo In Slowing Cartilage Loss In Knees Of Osteoarthritis Patients
  74. Two-Year Data Reinforce Effect Of ACTEMRA(R) (tocilizumab) In Inhibiting Progression Of Joint Damage And Improving Physical Function In Arthritis
  75. Breakthrough Treatment For Rheumatoid Arthritis Offers New Hope To Patients
  76. Treating Gum Disease Helps Rheumatoid Arthritis Sufferers
  77. Can Inflammatory Arthritis Be 'Worse Than Death'?
  78. Association Between Rheumatoid Arthritis And Poor Sleep In Women
  79. Exercise Improves Functional And Psycological Ability And Reduces Steroid Need In Rheumatoid Arthritis
  80. New Treatment Strategy Offers Hope To RA Patients Who Failed All Other Therapies
  81. The Beneficial Effects Of Pregnancy And Childbearing On Arthritic Conditions May Be More Long-Term Than Previously Understood
  82. Disclosing Feelings May Help The Course Of Rheumatoid Arthritis
  83. Cimzia(R), The Only PEGylated Anti-TNF, Recommended For Approval In The EU For Rheumatoid Arthritis
  84. Discovery Of New Trigger For Chronic Inflammation In Rheumatoid Arthritis
  85. Nearly Half Of Rheumatoid Arthritis Sufferers Feel Early Treatment Would Have Given Them More Independence
  86. Osteoarthritis A Major Consequence Of Obesity Epidemic, Claims Charity In New Report
  87. Disease Markers That Will Aid Arthritis Research
  88. Using Ultrasound To Detect Early Signs Of Osteoarthritis
  89. Rheumatoid Arthritis Is Worse In Poorer Countries
  90. GlaxoSmithKline And Genmab Announce Top-line Results For Ofatumumab In Rheumatoid Arthritis
  91. Link Between Pain In Rheumatoid Arthritis Patients And Depression/Inflammation
  92. Addition Of A TNF Antagonist Better Option For Patients With Early Rheumatoid Arthritis Who Have Poor Response To Methotrexate
  93. Tissue Engineering Could Yield Cure, Prevention For Osteoarthritis
  94. Studies Show Dramatic Decline In Rheumatoid Vasculitis In US Veterans
  95. Compliance With NICE Recommendations For The Management Of Rheumatoid Arthritis (RA) Now Made Easier
  96. Breakthrough Genetic Test Helps Doctors Assess Risk Of Developing Psoriatic Arthritis (PsA)
  97. Biologics For Rheumatoid Arthritis Work, But Which Is Best?
  98. New Biologic Drug Is Effective Against Rheumatoid Arthritis
  99. Insufficient Evidence To Recommend TENS For Osteoarthritis
  100. Trial Raises Doubts Over Alternative Pain Therapy For Arthritis
  101. Magnetic And Copper Bracelets Ineffective Against Pain Of Arthritis, Controlled Study
  102. Phase III Study Showed Two Years Of ACTEMRA(R) (tocilizumab) Inhibited Progression Of Joint Damage And Improved Disease Remission
  103. New SIMPONI(TM) Data Show Long-Term Efficacy In Treatment Of Rheumatoid Arthritis
  104. Lubris, Biomodels Report On Potential New Therapy For Osteoarthritis
  105. Updated Data From Randomized Controlled Phase II Study Evaluating Oral Apremilast In Psoriatic Arthritis Demonstrates Sustained Response At Six Months
  106. FDA Approves New Test To Aid In The Diagnosis Of Rheumatoid Arthritis
  107. Growing Cartilage From Stem Cells
  108. Tocilizumab Shows Sustained Efficacy In Rheumatoid Arthritis
  109. Link Between Pain Thresholds, Inflammation And Sleep Problems In Arthritis Patients
  110. Anti-tumor Necrosis Factor Treatment Does Not Increase Cancer Risk In Rheumatoid Arthritis Patients, Study Finds
  111. Tai Chi Exercise Reduces Knee Osteoarthritis Pain In The Elderly
  112. New Tool To Accelerate Discovery Of Autoimmune Disease Mechanisms And Therapies
  113. Judgement In Favour Of NICE On Judicial Review Of Abatacept For Rheumatoid Arthritis Guidance
  114. Adeona Announces Publication Of Results Of 160 Patient Phase 2 Clinical Trial Of Oral DnaJP1 For Rheumatoid Arthritis